Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter: Thursday, Oct 30, 2025.
Stock Region Penny Picks Watchlist Newsletter: Thursday, Oct 30, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now. https://stockregion.net
Disclaimer: The following is for informational purposes only and does not constitute financial advice. The stock market is inherently risky, and you should always conduct your own research and consult with a qualified financial professional before making any investment decisions. We are not liable for any losses you may incur.**
What a wild Thursday it’s been! The market felt like it had a little bit of everything today – some absolute rockets, some head-scratchers, and a few solid, under-the-radar moves. Let’s break down what caught our eye and what we’re keeping on the watchlist.
Today’s Big Movers & Headliners
$INTS (Intensity Therapeutics, Inc.)
Wow. Just... wow. This is the kind of pre-market move we all dream about. Waking up to see $INTS up 179% at $.75 is an absolute shot of adrenaline. The catalyst? A major publication in a Lancet-associated journal for their cancer treatment clinical results. This isn’t just fluff; it’s significant scientific validation. The volume is going to be insane on this one. The question is, can it hold these gains or will it be a classic pre-market pump and dump? I’m watching this one closely, but with extreme caution. Taking profits if you were in early is never a bad idea.
$AMZN (Amazon.com, Inc.)
The beast does it again. After the bell, Amazon dropped a monster earnings report, smashing estimates on both earnings per share and revenue. Beating estimates by over 24% is no small feat for a company of this size. It’s a reminder that even in a choppy market, the mega-caps can still deliver the goods. This report gives a nice boost of confidence to the tech sector and the market as a whole. Expect a positive ripple effect tomorrow.
$VIVK (Vivakor, Inc.)
This one popped up on my radar in a big way. Launching full-scale operations with a $24 million commodity transaction is a massive statement of intent. It shows they’re not just testing the waters; they’re diving in headfirst. This could be the start of some serious revenue generation. I’m adding this to my “watch very carefully” list because moves like this often precede a significant re-rating of a stock.
The Curious Case of $CERO
$CERO (CERo Therapeutics Hldgs)
This is market whiplash in its purest form. This morning, we see a “Buy” rating maintained with a ludicrous $30 price target while the stock is trading at a measly $.36. My first thought was, “Okay, someone knows something BIG.” Then, minutes later, BAM! News drops that the stock will be suspended from trading tomorrow. What a mess. It’s a harsh lesson that analyst targets can sometimes be completely disconnected from reality. Hopefully, nobody got trapped in that chaos.
Other Tickers on Our Radar
$MNTS (Momentus Inc.): New contract and a revenue-sharing agreement? Yes, please. Partnership news is always a good sign, and this deal with DPhi Space sounds promising for future cash flow.
$SEGG (SEGG Media): A $300 million move into Web3 is a bold, ambitious play. This positions them as a serious player in the digital asset space. It’s a long-term story, but one I’m definitely interested in following.
$MBRX (Moleculin Biotech): Highlighting a Phase 3 trial at a major medical meeting is great for visibility. Biotech is all about catalysts, and this keeps the spotlight on their AML drug.
$CVU (CPI Aerostructures): A contract with Raytheon is as solid as it gets. Defense contracts mean reliable revenue. This is a nice, steady-eddie type of news that builds a company’s foundation.
$QCLS (Q/C Technologies): Launching a proprietary “Quantum-Class” product sounds incredibly futuristic and could be a huge differentiator. Tech like this can create a moat around a company. One to watch.
$LNAI (Lunai Bioworks): AI and biotech are a powerful combo. Using it to detect neurotoxic compounds early is fascinating. This feels like a ground-floor opportunity in a cutting-edge field.
$STEX (Streamex Corp.): Escaping the threat of delisting is a huge win. The Nasdaq approval provides stability and restores some investor confidence. Now, let’s see what they say at the shareholder meeting on Nov 4th.
That’s a wrap for today! It was a day of powerful moves and important lessons. Keep your eyes open and your stop losses tight. See you in the morning!
Final Disclaimer: Remember, we are not financial advisors. All commentary and opinions expressed here are for entertainment and informational purposes only. Investing involves risk, including the potential loss of principal. Do your own due diligence before making any investment decisions.**